See the DrugPatentWatch profile for Cosela
What is Cosela?
Cosela is the brand name for trilaciclib, a medicine used in cancer care to help protect the bone marrow. It is designed to reduce the severity of chemotherapy-induced bone marrow suppression, which can lead to problems like low blood counts (including neutropenia). [1]
How does Cosela work?
Trilaciclib targets the cells that support blood-cell production and is intended to prevent or lessen the drop in blood counts caused by chemotherapy. By helping maintain bone marrow function during chemo, it aims to reduce complications related to low white blood cells. [1]
What is Cosela used for?
Cosela (trilaciclib) is used to help manage risk of chemotherapy-induced bone marrow suppression in patients receiving certain cancer treatments. [1]
What side effects do people ask about?
Commonly discussed side effects for medicines in this category can include symptoms related to the body’s response during treatment (for example, nausea or other typical treatment-related effects). The exact side-effect profile depends on the regimen and patient factors. [1]
Is Cosela a chemotherapy?
No. Cosela (trilaciclib) is not chemotherapy. It is a supportive-care medicine that works to protect the bone marrow during chemotherapy rather than directly treating the tumor. [1]
Where can I find official prescribing information?
You can review the most up-to-date details—indications, dosing, warnings, and full side-effect listings—through the product’s official labeling and prescribing information. [1]
Sources
- https://www.cosela.com/